When we first began our work, we wanted to make a real impact and get involved in ushering in a new age of medical technology and progress. To that end, we have continued to grow as an organization every year, with the range of activities we do increasing along with our reach and influence. We have done a lot of things in the last few years since we first created our non-profit organization, and we would like to share some of those achievements with you here.
Since we launched our research fundraising platform Lifespan.io in 2015, we have raised over $390,000 for important aging research and worked with institutions including Harvard Medical School and the SENS Research Foundation. You can click on the project slides below to go to the campaign pages where you can learn more about each project.
SPEADING THE WORD
We work to make high-impact collaborations with large-scale content creators on platforms like YouTube in order to inform and engage an ever-widening segment of the population on the topic of longevity research. We welcome the opportunity to work on more such initiatives; feel free to contact us if you are a content creator looking to produce well-informed videos on the subject of aging and life extension.
Why Age? Should We End Aging Forever? – Kurzgesagt
How to Cure Aging – During Your Lifetime? – Kurzgesagt
This Is How You Could Live An Extra 100 Years – Life Noggin
A TOP RATED NON-PROFIT
ANNUAL CONFERENCES TO SUPPORT THE INDUSTRY
In July 2018, we hosted the Ending Age-related diseases 2018 conference at the Cooper Union in the heart of New York City. The conference saw various industry experts and thought leaders come together for an action-packed day of research and biotech business talks and panels. Due to the success of the event, we will hold a conference every year and expand the increase the scale of the event
In 2019 we launched a webinar series where our monthly patrons, the Lifespan Heroes, are given the opportunity to join live discussion panels with the researchers who are working on solving aging. Our April 8th, 2019 episode saw Dr. Mike Lustgarten, Dr. Amy Proal, and Dr. Cosmo Mielke join hosts Dr. Oliver Medvedik and Steve Hill for a discussion about the microbiome and how it relates to aging.
REPORTING THE LATEST NEWS
Since January 2017, we have been reporting on the latest news and happenings in the aging research field. We interview the leading figures in rejuvenation biotech and aging research, report on the latest developments in the industry, create advocacy articles exploring the ethics and social issues of longer lives, and produce educational articles about the biology of aging.
Even More News
- The January edition of Journal Club, hosted by Dr. Oliver Medvedik, took a look at the results of a recent human...
A MONTHLY NEWS PODCAST
Brought to you by Nicola Bagalà, the Rejuvenation Roundup is our monthly digest, which takes a look at the big news stories involving the industry and helps keep you informed of current developments in the aging research field. To accompany the monthly Rejuvenation Roundup, as of July, we also began to include a podcast version that takes a deeper look at some of the key stories from that particular month and is hosted by Ryan O’Shea of the Future Grind podcast. You can listen to the latest episode below; for more, check out our Rejuvenation Roundup page.
ADVOCATING FOR AGING RESEARCH
We are always busy advocating for aging research and activism. LEAF Director Elena Milova was featured in Springer with co-author Ilia Stambler in a publication entitled “Longevity Activism”.
There is now an emerging international social advocacy movement dedicated to promotion of biomedical research and development to alleviate aging-related morbidity, extend healthy period of life, and improve healthy longevity for the elderly population. It is commonly referred to by the activists as the “longevity movement” or “longevity research and advocacy movement,” as well as “healthy life extension movement.” It is a “hybrid” between the aged rights advocacy, patient advocacy, and science advocacy, as it emphasizes the need to implement preventive medicine to improve health care for the elderly around the world via enhanced medical scientific research with a special focus on the mechanisms of biological aging.
The goals of the movement, defined by the organizations, initiative groups, and individual activists representing it, are the following: (a) to increase public awareness of the plausibility and desirability to bring the processes of aging under medical control, thus extending healthy human life span, delaying the manifestation of age-related diseases, and improving health in the older age; (b) to foster the improvement of the local and global legislation concerning health across the life course, aging, health and well-being of the elderly, and medical research with a special focus on the mechanisms of aging; (c) to allocate more public funding to fundamental and translational research on the mechanisms of aging and age-related diseases; (d) to increase the interest of the investment industry in supporting biotechnology companies developing innovative drugs and therapies targeting the underlying mechanisms of aging and thus able to prevent, delay, or cure age-related diseases; (e) to promote clinical implementation of the evidence-based medical and lifestyle means to extend healthy human life span.
The movement embraces the recent advances of biomedical science proving the possibility to intervene into the degenerative processes of aging to slow down, delay, prevent, and reverse age-related damage accumulation and seeks to enhance and accelerate such advances. The movement is still young and emerging and is not yet strongly related to other forms of health-care advocacy. But a stronger relation is hoped for.
SUPPORTING POLICY CHANGE
We actively support and drive positive policy change in healthcare and the regulatory system. We work with other groups to engage with the FDA, support freedom of scientific knowledge, take part in community efforts to change policy, and interview lobbyists engaged with high level organizations such as the WHO.
BRINGING INVESTORS AND RESEARCHERS TOGETHER
In early 2018 we created the Longevity Investors Network (LIN), a project designed to create a network of investors interested in aging research as well as identifying promising startups working in the rejuvenation biotechnology space. The LIN meets every month and new companies working on therapies targeting the aging processes get to pitch to the network of investors, this brings researchers and investors together to help drive progress and funding.
THE REJUVENATION ROADMAP
In 2018 we launched the Rejuvenation Roadmap, a curated database tracking the various therapies targeting the aging processes in order to delay, prevent, or even reverse age-related diseases. The roadmap breaks down aging into nine categories of damage, known as the hallmarks, and shows which projects are targeting which hallmarks as well as how far along the clinical trial process they are. This is your one stop shop to see how things are progressing and how far we might be from these technologies being available.